Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 243

1.

Treatment patterns of advanced malignant melanoma (stage III-IV) - A review of current standards in Europe.

Harries M, Malvehy J, Lebbe C, Heron L, Amelio J, Szabo Z, Schadendorf D.

Eur J Cancer. 2016 Apr 22. pii: S0959-8049(16)00049-6. doi: 10.1016/j.ejca.2016.01.011. [Epub ahead of print] Review.

PMID:
27118416
2.

Recurrent NRAS mutations in pulmonary Langerhans cell histiocytosis.

Mourah S, How-Kit A, Meignin V, Gossot D, Lorillon G, Bugnet E, Mauger F, Lebbe C, Chevret S, Tost J, Tazi A.

Eur Respir J. 2016 Apr 13. pii: ERJ-01677-2015. doi: 10.1183/13993003.01677-2015. [Epub ahead of print]

PMID:
27076591
3.

EMMPRIN/CD147 is an independent prognostic biomarker in cutaneous melanoma.

Caudron A, Battistella M, Feugeas JP, Pages C, Basset-Seguin N, Mazouz Dorval S, Funck Brentano E, Sadoux A, Podgorniak MP, Menashi S, Janin A, Lebbé C, Mourah S.

Exp Dermatol. 2016 Apr 6. doi: 10.1111/exd.13022. [Epub ahead of print]

PMID:
27060463
4.

Anti-PD1-induced collagenous colitis in a melanoma patient.

Baroudjian B, Lourenco N, Pagès C, Chami I, Maillet M, Bertheau P, Bagot M, Gornet JM, Lebbé C, Allez M.

Melanoma Res. 2016 Jun;26(3):308-11. doi: 10.1097/CMR.0000000000000252.

PMID:
26990271
5.

[Melanoma, from diagnosis to treatment].

Baroudjian B, Pagès C, Lebbé C.

Rev Infirm. 2016 Mar;65(219):16-8. doi: 10.1016/j.revinf.2015.12.022. French.

PMID:
26944639
6.

An unusual case of primary cutaneous Ewing sarcoma in an adult.

Barreau M, Chevallier JM, Pontoizeau J, Bazille C, Lebbé C, Verneuil L, Dompmartin A.

Int J Dermatol. 2016 Mar 3. doi: 10.1111/ijd.13158. [Epub ahead of print] No abstract available.

PMID:
26938472
7.

Mechanisms Underpinning Increased Plasma Creatinine Levels in Patients Receiving Vemurafenib for Advanced Melanoma.

Hurabielle C, Pillebout E, Stehlé T, Pagès C, Roux J, Schneider P, Chevret S, Chaffaut C, Boutten A, Mourah S, Basset-Seguin N, Vidal-Petiot E, Lebbé C, Flamant M.

PLoS One. 2016 Mar 1;11(3):e0149873. doi: 10.1371/journal.pone.0149873. eCollection 2016.

8.

Validation of a preclinical model for assessment of drug efficacy in melanoma.

Delyon J, Varna M, Feugeas JP, Sadoux A, Yahiaoui S, Podgorniak MP, Leclert G, Dorval SM, Dumaz N, Janin A, Mourah S, Lebbé C.

Oncotarget. 2016 Feb 20. doi: 10.18632/oncotarget.7541. [Epub ahead of print]

9.

Association of Vemurafenib and Pipobroman Enhances BRAF-CRAF Dimerization in Squamous Cell Carcinoma.

Cassius C, Pages C, Roux J, Lhote R, Lavocat R, Réa D, Bagot M, Mourah S, Battistella M, Lebbé C, Dumaz N.

J Invest Dermatol. 2016 Feb 15. pii: S0022-202X(16)00459-0. doi: 10.1016/j.jid.2015.12.047. [Epub ahead of print] No abstract available.

PMID:
26854489
10.

Squamous Cell Carcinoma Following Photodynamic Therapy for Cutaneous Bowen's Disease in a Series of 105 Patients.

Ratour-Bigot C, Chemidling M, Montlahuc C, Abirached G, Madjlessi N, Bullier C, Battistella M, Bagot M, Lebbe C, Basset-Seguin N.

Acta Derm Venereol. 2015 Dec 30. doi: 10.2340/00015555-2330. [Epub ahead of print]

11.

PARKIN Inactivation Links Parkinson's Disease to Melanoma.

Hu HH, Kannengiesser C, Lesage S, André J, Mourah S, Michel L, Descamps V, Basset-Seguin N, Bagot M, Bensussan A, Lebbé C, Deschamps L, Saiag P, Leccia MT, Bressac-de-Paillerets B, Tsalamlal A, Kumar R, Klebe S, Grandchamp B, Andrieu-Abadie N, Thomas L, Brice A, Dumaz N, Soufir N.

J Natl Cancer Inst. 2015 Dec 17;108(3). pii: djv340. doi: 10.1093/jnci/djv340. Print 2016 Mar.

PMID:
26683220
12.

Donor-derived stem-cells and epithelial mesenchymal transition in squamous cell carcinoma in transplant recipients.

Verneuil L, Leboeuf C, Bousquet G, Brugiere C, Elbouchtaoui M, Plassa LF, Peraldi MN, Lebbé C, Ratajczak P, Janin A.

Oncotarget. 2015 Dec 8;6(39):41497-507. doi: 10.18632/oncotarget.6359.

13.

Reply to 'Plasma vemurafenib concentrations in advanced BRAFV600mut melanoma patients: impact on tumour response and tolerance' by Funck-Brentano et al.

Goldwirt L, Chami I, Feugeas JP, Pages C, Brunet-Possenti F, Allayous C, Baroudjian B, Madelaine I, Sauvageon H, Mourah S, Lebbé C.

Ann Oncol. 2016 Feb;27(2):363-4. doi: 10.1093/annonc/mdv538. Epub 2015 Nov 16. No abstract available.

PMID:
26578723
14.

Dramatic transient improvement of metastatic BRAF(V600E)-mutated Langerhans cell sarcoma under treatment with dabrafenib.

Mourah S, Lorillon G, Meignin V, Vercellino L, de Margerie-Mellon C, Pages C, Goldwirt L, How-Kit A, Tost J, Lebbe C, Tazi A.

Blood. 2015 Dec 10;126(24):2649-52. doi: 10.1182/blood-2015-06-650036. Epub 2015 Oct 14. No abstract available.

PMID:
26468227
15.

Integrating first-line treatment options into clinical practice: what's new in advanced melanoma?

Dummer R, Schadendorf D, Ascierto PA, Larkin J, Lebbé C, Hauschild A.

Melanoma Res. 2015 Dec;25(6):461-9. doi: 10.1097/CMR.0000000000000200.

PMID:
26426764
16.

BRAF inhibitor rechallenge in patients with advanced BRAF V600-mutant melanoma.

Roux J, Pages C, Malouf D, Basset Seguin N, Madjlessi N, Baccard M, Comte C, Archimbaud A, Battistella M, Viguier M, Mourah S, Bagot M, Lebbe C.

Melanoma Res. 2015 Dec;25(6):559-63. doi: 10.1097/CMR.0000000000000196.

PMID:
26397052
17.

Prognostic Value of 25-hydroxyvitamin D3 Levels at Diagnosis and During Follow-up in Melanoma Patients.

Saiag P, Aegerter P, Vitoux D, Lebbé C, Wolkenstein P, Dupin N, Descamps V, Aractingi S, Funck-Brentano E, Autier P, Dragomir M, Boniol M.

J Natl Cancer Inst. 2015 Sep 15;107(12):djv264. doi: 10.1093/jnci/djv264. Print 2015 Dec.

PMID:
26376687
18.

Diagnosis and treatment of Merkel Cell Carcinoma. European consensus-based interdisciplinary guideline.

Lebbe C, Becker JC, Grob JJ, Malvehy J, Del Marmol V, Pehamberger H, Peris K, Saiag P, Middleton MR, Bastholt L, Testori A, Stratigos A, Garbe C; European Dermatology Forum (EDF), the European Association of Dermato-Oncology (EADO) and the European Organization for Research and Treatment of Cancer (EORTC).

Eur J Cancer. 2015 Nov;51(16):2396-403. doi: 10.1016/j.ejca.2015.06.131. Epub 2015 Aug 6. Review.

PMID:
26257075
19.

Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.

Stratigos A, Garbe C, Lebbe C, Malvehy J, del Marmol V, Pehamberger H, Peris K, Becker JC, Zalaudek I, Saiag P, Middleton MR, Bastholt L, Testori A, Grob JJ; European Dermatology Forum (EDF); European Association of Dermato-Oncology (EADO); European Organization for Research and Treatment of Cancer (EORTC).

Eur J Cancer. 2015 Sep;51(14):1989-2007. doi: 10.1016/j.ejca.2015.06.110. Epub 2015 Jul 25. Review.

PMID:
26219687
20.

Diagnosis and treatment of dermatofibrosarcoma protuberans. European consensus-based interdisciplinary guideline.

Saiag P, Grob JJ, Lebbe C, Malvehy J, del Marmol V, Pehamberger H, Peris K, Stratigos A, Middelton M, Basholt L, Testori A, Garbe C.

Eur J Cancer. 2015 Nov;51(17):2604-8. doi: 10.1016/j.ejca.2015.06.108. Epub 2015 Jul 16.

PMID:
26189684
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk